CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY
CTNI-14. 放射治疗与替莫唑胺治疗高危低级别胶质瘤的比较。EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) III期研究中期随访13年后的最终结果
期刊:Molecular Neurodegeneration
影响因子:17.5
doi:10.1186/s13024-020-00368-6
Hijaz, Baraa A; Volpicelli-Daley, Laura A; Baumert, Brigitta G; Hegi, Monika E; Van den Bent, Martin; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khe; Brandes, Alba A; Sargos, Paul; Taphoorn, Martin; Vauleon, Elodie; Phillips, Claire; Kros, Johan M; Bady, Pierre; Wick, Wolfgang; Enting, Roelien; Reni, Michele; Thiessen, Brian; Dhermain, Frederic; Bromberg, Jacoline; Jacob, Julian; Reijneveld, Jaap C; Chinot, Olivier; Gijtenbeek, Anja; Rossiter, John; Lentz, Marie-Ange; Balana, Carmen; Azevedo, Ana Luisa Silva; Clement, Paul M; Berghoff, Anna; Tzuk, Tzahala; Weller, Michael; Nordal, Robert; Rees, Jeremy; Lacombe, Denis; Mason, Warren P; Stupp, Roger